LIXT
Lixte Biotechnology Holdings Inc
3.70$
-1.3%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 98.2% | 97.8% | 100.0% | 99.6% | 100.0% | 100.0% | 83.3% | 100.0% | 40.7% | 31.4% | 72.4% | |
| 97.5% | 97.6% | 95.1% | 97.3% | 96.6% | 90.7% | 91.4% | 74.6% | 53.1% | 40.1% | 29.9% | 47.5% | |
| 97.5% | 97.6% | 95.1% | 97.3% | 96.6% | 90.7% | 91.4% | 74.6% | 98.3% | 40.1% | 29.9% | 47.5% | |
| 6.0% | 7.3% | 12.9% | 15.8% | 19.4% | 27.8% | 23.5% | 45.2% | 9.6% | 13.9% | 15.5% | 6.2% | |
| 6.0% | 7.3% | 12.9% | 15.8% | 19.4% | 27.8% | 23.5% | 45.2% | 9.6% | 10.5% | 11.3% | 5.6% | |
| 4.2% | 0.0% | 12.9% | -15.8% | – | – | – | – | – | 5.2% | 5.5% | 3.5% | |
| 4.2% | 3.6% | 6.9% | 4.9% | 4.3% | 7.3% | 7.4% | 7.8% | 4.3% | 3,427.8% | 3.6% | – | |
| 94.0% | 92.7% | 87.1% | 84.2% | 80.6% | 72.2% | 76.5% | 54.8% | 90.4% | 75.9% | 73.1% | 89.7% | |
| -906.4% | -1,125.2% | -1,377.8% | -1,891.7% | -3,033.8% | -4,545.4% | -3,485.4% | -4,505.6% | -1,022.0% | -456.1% | -552.2% | -233.4% | |
| 39.6% | 52.2% | 62.7% | 84.3% | 132.6% | 196.3% | 163.2% | 228.9% | 113.6% | 380.2% | 100.2% | 50.6% |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.